Trial intelligence / Profile preview

Phase 3 trial of VivaGel for treatment of bacterial vaginosis

2012-000752-33Phase 3Completed

Sponsor
Starpharma
Start
Mar 2012
Modality
Peptides, Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of astodrimer in bacterial vaginosis (BV), sponsored by Starpharma. Started Mar 2012; status: completed.

02

Drugs

astodrimer
03

Conditions

bacterial vaginosis (BV)

Beyond the preview

Go deeper on 2012-000752-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-000752-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call